Chronic Sinusitis and TJ-50
- Conditions
- Chronic Sinusitis
- Registration Number
- JPRN-jRCTs031180048
- Lead Sponsor
- Hatakeyama Hiromitsu
- Brief Summary
In this study comparing the efficacy and safety of the conventional treatment group and the TJ-50 group for postoperative chronic sinusitis, there was no significant difference between the two groups in the total change in the total score of Visit 4 from before admission. In addition, no side effects were observed in either group. Although the superiority of the TJ-50 combination group could not be demonstrated in this study, it is considered as a treatment option for postoperative chronic sinusitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 25
1) The patient is diagnosed with chronic sinusitis 2) The patient is planned treatment by ESS(Endoscopic Sinus Surgery) 3) The patient can be treated with long-term, low-dose macrolide. 4) 20 to 80 years old 5) Both gender6)Written informed consent of this study is obtained from the patient
1) The patients scheduled to undergo surgical procedures other than ESS as a treatment for chronic sinusitis 2) The patients suspected of typical eosinophilic sinusitis 3) The patients complicated of aspirin asthma 4) The patients complicated with bronchial asthma 5) The patients complicated of NSAIDs allergy 6) Pregnant women, lactating women, and patients who have the possibility or intention of pregnancy 7) The patients who are merging psychosis or psychiatric symptoms and are considered difficult to participate in the study 8) The patients judged unsuitable by researchers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method